These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10850108)

  • 41. tPA in daily clinical practice.
    Nighoghossian N
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12733503
    [No Abstract]   [Full Text] [Related]  

  • 42. Building a "brain attack" team to administer thrombolytic therapy for acute ischemic stroke.
    Hill MD; Barber PA; Demchuk AM; Sevick RJ; Newcommon NJ; Green T; Buchan AM
    CMAJ; 2000 May; 162(11):1589-93. PubMed ID: 10862236
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombolysis in acute ischaemic stroke: time for a rethink?
    Alper BS; Malone-Moses M; McLellan JS; Prasad K; Manheimer E
    BMJ; 2015 Mar; 350():h1075. PubMed ID: 25786912
    [No Abstract]   [Full Text] [Related]  

  • 44. De-novo thrombolysis for recurrent stroke in a patient with prior history of thrombolysis.
    Arsava EM; Topcuoglu MA
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):605-7. PubMed ID: 20644467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The 4.5-hour time window for intravenous thrombolysis with intravenous tissue-type plasminogen activator is not firmly established.
    Wechsler LR
    Stroke; 2014 Mar; 45(3):914-5. PubMed ID: 24526061
    [No Abstract]   [Full Text] [Related]  

  • 46. Dissociation of severity of stroke and aphasia recovery early after intravenous recombinant tissue plasminogen activator thrombolysis.
    Kremer C; Kappelin J; Perren F
    J Clin Neurosci; 2014 Oct; 21(10):1828-30. PubMed ID: 24852905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prehospital triage to primary stroke centers and rate of stroke thrombolysis.
    Prabhakaran S; O'Neill K; Stein-Spencer L; Walter J; Alberts MJ
    JAMA Neurol; 2013 Sep; 70(9):1126-32. PubMed ID: 23817961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advances and challenges in treatment and prevention of ischemic stroke.
    Grossman AW; Broderick JP
    Ann Neurol; 2013 Sep; 74(3):363-72. PubMed ID: 23929628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomised trials of endovascular treatment of stroke are needed.
    Ciccone A; Sterzi R
    Lancet Neurol; 2010 Jan; 9(1):30; author reply 31-2. PubMed ID: 20083033
    [No Abstract]   [Full Text] [Related]  

  • 50. Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided.
    Boode B; Welzen V; Franke C; van Oostenbrugge R
    Cerebrovasc Dis; 2007; 23(4):294-8. PubMed ID: 17199087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is there a bad time for intravenous thrombolysis? The experience of Polish stroke centers.
    Karliński M; Kobayashi A; Sobolewski P; Lisewski P; Romanowicz S; Fryze W; Nyka W; Zięba M; Dorobek M; Członkowska A
    Neurol Neurochir Pol; 2014; 48(1):45-51. PubMed ID: 24636770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictors of long-term outcome after intravenous or intra-arterial recombinant tissue plasminogen activator treatment in the eastern Hungarian thrombolysis database.
    Fekete K; Márton S; Tóth J; Csiba L; Fekete I; Bereczki D
    J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):117-24. PubMed ID: 25440339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stroke thrombolysis in England: an age stratified analysis of practice and outcome.
    Bray BD; Campbell J; Hoffman A; Tyrrell PJ; Wolfe CD; Rudd AG
    Age Ageing; 2013 Mar; 42(2):240-5. PubMed ID: 23174425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
    Yan X; Hu HT; Liu S; Sun YH; Gao X
    Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is intraarterial tPA within 3 hours the treatment of choice for selected stroke patients?: No.
    Lindley RI
    Stroke; 2009 Jul; 40(7):2613-4. PubMed ID: 19443793
    [No Abstract]   [Full Text] [Related]  

  • 56. [Recommendation of the Polish Neurologic Society and the Polish Neurosurgical Society regarding stroke prevention and therapy].
    ;
    Neurol Neurochir Pol; 2003; 37 Suppl 6():3-41. PubMed ID: 15174230
    [No Abstract]   [Full Text] [Related]  

  • 57. A prototype worldwide survey of diagnostic and treatment modalities for stroke.
    Aiyagari V; Pandey DK; Testai FD; Grysiewicz RA; Tsiskaridze A; Sacks C; Ogun Y; Ogunrin OA; Uthman BM; Lindsay P; Gorelick PB
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):290-6. PubMed ID: 25440332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Recommendations of the European Stroke Initiative for the management and treatment of stroke].
    Hacke W; Kaste M; Olsen TS; Orgogozo JM; Bogousslavsky J;
    Nervenarzt; 2001 Oct; 72(10):807-19. PubMed ID: 11688185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selecting relevant and feasible measurement instruments for the revised Dutch clinical practice guideline for physical therapy in patients after stroke.
    Otterman N; Veerbeek J; Schiemanck S; van der Wees P; Nollet F; Kwakkel G
    Disabil Rehabil; 2017 Jul; 39(14):1449-1457. PubMed ID: 27374876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Veterans Affairs/Department of Defense Clinical Practice Guideline for the Management of Adult Stroke Rehabilitation Care: executive summary.
    Bates B; Choi JY; Duncan PW; Glasberg JJ; Graham GD; Katz RC; Lamberty K; Reker D; Zorowitz R; ;
    Stroke; 2005 Sep; 36(9):2049-56. PubMed ID: 16120847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.